Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial

Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial

Bibliographic Details
Main Authors: Nakanjako, Damalie, Ssinabulya, Isaac, Nabatanzi, Rose, Bayigga, Lois, Kiragga, Agnes, Joloba, Moses, Kaleebu, Pontiano, Kambugu, Andrew D., Kamya, Moses R., Sekaly, Rafick, Elliott, Alison, Mayanja-Kizza, Harriet
Format: Online
Language:English
Published: 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529480/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529480/

Similar Items